MedTrace Logo

Tunisian Lung Cancer Study

NCT06934499 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1334

Last updated 2025-06-04

No results posted yet for this study

Summary

This is a prospective, multicenter, observational, national study. Eligible patients will be recruited consecutively among subjects with proven lung cancer, including any disease stage withclinical, therapeutic and evolutive discription.

Conditions

  • Pulmonary Cancer

Sponsors & Collaborators

  • The Multidisciplinary Consultation Meeting Thoracic Oncology of the Abderrahmen Mami Hospital (ROTHAM)

    collaborator UNKNOWN

  • Tunisian Society of Respiratory Diseases and Allergology

    collaborator UNKNOWN

  • Tunisian Society of Medical Oncology

    collaborator UNKNOWN

  • Dacima Consulting

    lead OTHER

Principal Investigators

  • Soraya Fenniche, MD · Multidisciplinary consultation meeting Thoracic of the Abderrahmen Mami ROTHA Hospital

  • Nesrine Mejri, MD · Multidisciplinary consultation meeting Thoracic of the Abderrahmen Mami ROTHA Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-02
Primary Completion
2025-10-30
Completion
2026-10-30

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06934499 on ClinicalTrials.gov